Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
about
Physiological and pathological implications of 5-hydroxymethylcytosine in diseasesNext generation sequencing applications for breast cancer research.Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusIntensified surveillance for early detection of breast cancer in high-risk patientsAssociation between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer riskComparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument.Impact of Prophylactic Mastectomy in BRCA1/2 Mutation CarriersA risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsRisk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer.A summary of relationships between alternative splicing and breast cancer.Role of Breast Surgery in BRCA Mutation Carriers.Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families.Mammographic Density and Vitamin D Levels - A Cross-sectional Study.Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose RadiobiologyLong-term experiences with genetic consultation in people with hereditary breast and ovarian cancer.Increased single-strand annealing rather than non-homologous end-joining predicts hereditary ovarian carcinoma.Non-small cell neuroendocrine carcinoma of the ovary in a BRCA2-germline mutation carrier: A case report and brief review of the literature.Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity
P2860
Q26749375-C928BB75-B783-436E-8898-01B0E7F38B7AQ27690994-15683901-1CA6-401C-9CDB-4F1344ACEFB0Q28307436-6E6835D3-5906-49F8-AD06-59992639BBA1Q30392157-D8FE3D00-93ED-41E7-B2D9-6A61C4CE9D09Q31138546-630AAFF5-192C-4A05-ABC4-B75E2F0AD270Q33643070-44E439EB-8E86-40BE-A59E-184A1A1AA07DQ33739428-FD6295F5-5723-489D-A60F-F625DFAFD736Q33901361-38CA9906-389C-4762-81E8-CC6478F29BB3Q34288968-CF28DCDB-9C6B-4B3A-9444-1A733ADEF551Q34484846-9EB2717F-894F-4268-A99F-59BA2D97A7A8Q35050959-40EDBA7C-54C7-4690-AD3D-A67FC03E7E85Q35848518-814BC19F-3C7A-424E-9716-6E67C45AE1D8Q36295137-5C8E409A-0526-4652-8D0C-267949642A00Q36378283-023522A2-F36D-40AE-B84D-B874AEF8BBA5Q36457900-3322FDA3-A785-43DB-A597-EDA33E983B63Q36844285-BA1E80D9-7A08-4EBD-8613-74C86744F203Q36867985-19E3AE9A-03BF-4B02-9076-62F9C2801F9BQ37128441-9A7BFA15-98AC-4C6D-8250-7980121CD840Q37627536-D60DD4FE-C77A-4078-885E-0D6CFCBDEEDCQ37725110-7A9B3D1C-9728-4941-BFB3-EF7AA3F46042Q37740232-BED9D657-4DF7-4B50-B3B0-B31542A6E5D5Q38634134-10D51890-524E-4A72-B39B-FB94A6EEFFC0Q39695669-A25B8BFF-8B93-4114-95E8-F616EF0E1B3DQ47138752-18D69FF0-37DE-4C9C-9E83-F54AE1D4425FQ55389200-8C7A44A9-B67C-4767-986B-72155B456C16Q58797665-2A18DB08-84BF-4FB8-A264-AF1D2DC73901
P2860
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@ast
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@en
type
label
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@ast
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@en
prefLabel
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@ast
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@en
P2093
P2860
P1476
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
@en
P2093
Karin Kast
Kerstin Rhiem
Nina Ditsch
P2860
P304
P356
10.3238/ARZTEBL.2011.0323
P577
2011-05-13T00:00:00Z